Psychiatric medications, especially antidepressants, have been one of the targets of Kennedy’s “Make America Healthy Again” ...

GLP-1RAs significantly reduce major cardiovascular events, mortality, and other clinically significant complications in ...

Trying to keep up with new research on GLP-1s in kids is like “drinking from a fire hose,” Dr. Kelly, co-director of the ...

The latest type 2 diabetes (T2D) management guidance from the American Association of Clinical Endocrinology (AACE) covers newer diabetes medications, comorbidities, and — for the first time — ...

Glucagon-like peptide-1 (GLP-1) agonists like semaglutide (Ozempic) and dual GLP-1/GIP receptor agonists like tirzepatide (Mounjaro) are some of the most effective medications approved for the ...

GLP-1s posted ~$132B 2025 sales (+33.5% YoY), with weight-loss indications up 131% on a CAGR (5 year-compounded annual growth rate) basis, reinforcing volume—not price—as the primary driver of overall ...

Insulin for Type 2 Diabetes Why Doctors Choose GLP-1s Switching From Insulin to GLP-1s Taking Both Insulin and GLP-1s Insulin, a hormone medication used to regulate blood sugar, has long been one of ...

CHARLOTTESVILLE, Va. — A University of Virginia Center for Diabetes Technology-developed algorithm, paired with a continuous glucose monitor, can help users better manage their Type 2 diabetes by ...

Abstract: Type 1 diabetes treatment still poses difficulties because it has complex and time-varying glucose-insulin dynamics. The proposed study aims to provide a closed-loop insulin infusion system ...

Emerging diabetes therapies are transforming MASLD treatment by addressing both metabolic dysfunction and liver disease, with new approvals and a growing pipeline signaling a shift in care. A rapidly ...